Table 1.
Events | 0–3 days | 4–14 days | 15–30 days | Early (0–30 days) |
---|---|---|---|---|
Recurrence/intracranial bleeding (%) | 11 (3.6%) | 6 (1.9%) | 9 (2.9%) | 26 (8.4%) |
Thromboembolic events (%) | 4 (1.3%) | 5 (1.6%) | 6 (1.9%) | 15 (4.9%) |
Events | 0–3 days | 4–14 days | 15–30 days | Early (0–30 days) |
---|---|---|---|---|
Recurrence/intracranial bleeding (%) | 11 (3.6%) | 6 (1.9%) | 9 (2.9%) | 26 (8.4%) |
Thromboembolic events (%) | 4 (1.3%) | 5 (1.6%) | 6 (1.9%) | 15 (4.9%) |